Paper36949199
RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M and 17 others. Nature, 2023. Cited by 179 papers, by iCite.
Cite this record
ConductScience Library. RHOJ controls EMT-associated resistance to chemotherapy. Papers, record 36949199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| rho GTP-Binding Proteins | Major topic |
| Skin Neoplasms | Major topic |
| Actins | |
| Cell Line, Tumor | |
| Proteomics | |
| Animals | |
| Mice | |
| Gene Expression Profiling | |
| Genome |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 36949121 | Cancer cells remodel nuclear actin filaments to resist chemotherapy. | https://conductscience.org/library/papers/36949121 | PubMed |
| Comment in | 37106250 | EMT in chemoresistance. | https://conductscience.org/library/papers/37106250 | PubMed |
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27831506 | Causes of death among cancer patients. | Ann Oncol | 2017 | https://conductscience.org/library/papers/27831506 | PubMed |
| 2 | 29326430 | EMT in cancer. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29326430 | PubMed |
| 3 | 28397828 | EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28397828 | PubMed |
| 4 | 27368099 | EMT: 2016. | Cell | 2016 | https://conductscience.org/library/papers/27368099 | PubMed |
| 5 | 24875735 | Oncogenic roles of EMT-inducing transcription factors. | Nat Cell Biol | 2014 | https://conductscience.org/library/papers/24875735 | PubMed |
| 6 | 19336515 | Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19336515 | PubMed |
| 7 | 25086746 | ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. | Nat Cell Biol | 2014 | https://conductscience.org/library/papers/25086746 | PubMed |
| 8 | 26560028 | Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. | Nature | 2015 | https://conductscience.org/library/papers/26560028 | PubMed |
| 9 | 26560033 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. | Nature | 2015 | https://conductscience.org/library/papers/26560033 | PubMed |
| 10 | 27889319 | Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition. | Cell Stem Cell | 2017 | https://conductscience.org/library/papers/27889319 | PubMed |
| 11 | 34902824 | NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. | J Natl Compr Canc Netw | 2021 | https://conductscience.org/library/papers/34902824 | PubMed |
| 12 | 29670281 | Identification of the tumour transition states occurring during EMT. | Nature | 2018 | https://conductscience.org/library/papers/29670281 | PubMed |
| 13 | 22971344 | RhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damage. | Cancer Res | 2012 | https://conductscience.org/library/papers/22971344 | PubMed |
| 14 | 28753606 | The RhoJ-BAD signaling network: An Achilles' heel for BRAF mutant melanomas. | PLoS Genet | 2017 | https://conductscience.org/library/papers/28753606 | PubMed |
| 15 | 32984327 | MKL1 Mediates TGF-β Induced RhoJ Transcription to Promote Breast Cancer Cell Migration and Invasion. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32984327 | PubMed |
| 16 | 21148427 | RhoJ/TCL regulates endothelial motility and tube formation and modulates actomyosin contractility and focal adhesion numbers. | Arterioscler Thromb Vasc Biol | 2011 | https://conductscience.org/library/papers/21148427 | PubMed |
| 17 | 32822001 | Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics. | Neurotherapeutics | 2020 | https://conductscience.org/library/papers/32822001 | PubMed |
| 18 | 21363960 | Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. | Genes Dev | 2011 | https://conductscience.org/library/papers/21363960 | PubMed |
| 19 | 10967094 | Characterization of TCL, a new GTPase of the rho family related to TC10 andCcdc42. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10967094 | PubMed |
| 20 | 26166705 | BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks. | Mol Cell | 2015 | https://conductscience.org/library/papers/26166705 | PubMed |
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919864 | 3D tissue model to patient atlas: dynamic network topology reveals PDAC chemoresistance bottlenecks. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/42919864 | PubMed |
| 42860404 | Targeting receptor tyrosine kinases: from molecular mechanisms to clinical therapeutics. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42860404 | PubMed |
| 42807396 | Bioactive Constituents of Ginseng in Cancer Therapy: Molecular Mechanisms, Translational Potential, and Advanced Delivery Strategies. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807396 | PubMed |
| 42748914 | Single-cell and spatial multi-omics reveal a recurrent multicellular niche at the tumor-stroma interface in multidrug resistance. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42748914 | PubMed |
| 42613325 | Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42613325 | PubMed |
| 42602989 | Adaptive epithelial-mesenchymal bi-directional transition: A key invasive plasticity for tumor metastasis. | iScience | 2026 | https://conductscience.org/library/papers/42602989 | PubMed |
| 42583543 | LTB4R inhibits apoptosis and induces radiosensitivity by promoting the PI3K/AKT pathway in esophageal squamous cell carcinoma. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42583543 | PubMed |
| 42565737 | Multi-Omics Analysis Identifies Tryptophan Metabolism and Glycolysis as Potential Pathways Involved in the Protective Effects of Tormentic Acid Against Metabolic Associated Fatty Liver Disease. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/42565737 | PubMed |
| 42554156 | Immunohistochemical Expression of RhoJ Protein in Breast Carcinoma. | Appl Immunohistochem Mol Morphol | 2026 | https://conductscience.org/library/papers/42554156 | PubMed |
| 42543381 | Cancer drug response and resistance: molecular mechanisms and combating strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42543381 | PubMed |
| 42333231 | Pan-cancer signaling landscape linked to endothelial and immune Sphingosine-1-phosphate receptor 1 (S1PR1) expression. | In Silico Pharmacol | 2026 | https://conductscience.org/library/papers/42333231 | PubMed |
| 42277016 | Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42277016 | PubMed |
| 42230580 | C/EBPγ induces epithelial-mesenchymal transition and facilitates DNA double-strand break repair in lung adenocarcinoma cells. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42230580 | PubMed |
| 42203766 | Recurrence in the chemotherapy regimen of bladder carcinoma originates from quiescent epidermoid-like cells. | Nat Commun | 2026 | https://conductscience.org/library/papers/42203766 | PubMed |
| 42182196 | Bound for the nucleus: defining the molecular principles of cargo selection by importin 9. | bioRxiv | 2026 | https://conductscience.org/library/papers/42182196 | PubMed |
| 42143069 | Disrupting SOX2 self-association and condensate formation to overcome chemotherapeutic drug resistance in lung squamous cell carcinoma. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42143069 | PubMed |
| 42106340 | SPOP-mediated K27-linked non-degradative ubiquitination of KCNN3 suppressing HCC progression via the CTCF-SATB1 axis. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42106340 | PubMed |
| 42093646 | Rho GTPases in cancer resistance: mechanisms, vulnerabilities, and therapeutic opportunities. | Biochem Soc Trans | 2026 | https://conductscience.org/library/papers/42093646 | PubMed |
| 42082974 | Transforming tumor microenvironments: nanotechnology and gene therapy in cellular signaling and epigenetic insight into chemo-resistance. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42082974 | PubMed |
| 42050207 | HDAC8-mediated CAPZB desuccinylation enhances cytoskeleton remodeling to promote idiopathic pulmonary fibrosis. | Commun Biol | 2026 | https://conductscience.org/library/papers/42050207 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949199
GET https://conductscience.org/api/papers/v1/36949199/references?page=2